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http://dx.doi.org/10.1016/j.stemcr.2016.10.003SUMMARYGenetic changes in human pluripotent stem cells (hPSCs) gained during culture can confound experimental results and potentially jeop-
ardize the outcome of clinical therapies. Particularly common changes in hPSCs are trisomies of chromosomes 1, 12, 17, and 20. Thus,
hPSCs should be regularly screened for such aberrations. Although a number of methods are used to assess hPSC genotypes, there has
been no systematic evaluation of the sensitivity of the commonly used techniques in detecting low-level mosaicism in hPSC cultures.
We have performed mixing experiments to mimic the naturally occurring mosaicism and have assessed the sensitivity of chromosome
banding, qPCR, fluorescence in situ hybridization, and digital droplet PCR in detecting variants. Our analysis highlights the limits of
mosaicism detection by the commonly employed methods, a pivotal requirement for interpreting the genetic status of hPSCs and for
setting standards for safe applications of hPSCs in regenerative medicine.INTRODUCTION
The dual ability of human pluripotent stem cells (hPSCs) to
self-renew and differentiate into any cell type in the body
makes them a promising cell source for regenerative medi-
cine, disease modeling, and drug discovery (Takahashi
et al., 2007; Thomson et al., 1998). Such applications neces-
sitate the maintenance of large numbers of undifferenti-
ated, genetically stable cells. However, hPSCs are subject
to genetic changes in vitro and in the presence of selec-
tion pressures, the variants with changes that allow for
improved growth outcompete their neighbors and over-
take the culture (Draper et al., 2004; Olariu et al., 2010).
The commonly observed genetic changes in hPSCs are
non-random and involve gains of either parts or whole
chromosomes 1, 12, 17, and 20 (Amps et al., 2011; Taapken
et al., 2011), indicating that genes within these regions
confer selective advantage to variant cells (Avery et al.,
2013; Blum et al., 2009).
Genetic aberrations that arise in hPSCs during culture
can affect their behavior and confound experimental
results. Some of the variant cells with common genetic
changes show signs of neoplastic progression (Werbowet-
ski-Ogilvie et al., 2009), including reduced apoptosis (Avery
et al., 2013; Yang et al., 2008), growth-factor independence
(Werbowetski-Ogilvie et al., 2009) and higher cloning effi-
ciency (Barbaric et al., 2014; Enver et al., 2005). Genetic
changes can also affect the differentiation propensity of
hPSCs. For example, a culture-adapted H7 line displayed
a reduced tendency for differentiation to endoderm (Fazeli
et al., 2011). Similarly, variant cells with a gain of chromo-
some 20q11.1-11.2 showed differences in the hematopoi-
etic and neural differentiation protocols compared with998 Stem Cell Reports j Vol. 7 j 998–1012 j November 8, 2016 j ª 2016 The
This is an open access article under the CC BY license (http://creativecommotheir wild-type controls (Werbowetski-Ogilvie et al.,
2009). Altered patterns of differentiation caused by accrued
genetic changesmay significantly affect the use of such cell
lines in applications that require the production of differ-
entiated derivatives. Furthermore, the commonly observed
genetic changes in hPSCs are also frequently observed
in embryonal carcinoma cells, the stem cells of malig-
nant germ cell tumors termed teratocarcinomas (Harrison
et al., 2007). Indeed, gain of chromosome 12p is used as a
diagnostic marker for testicular germ cell tumors (Sandberg
et al., 1996).With hPSCs derivatives entering clinical trials,
a possibility that genetic changes may confer malignant
properties to hPSCs or their differentiated progeny is a
cause of regulatory concern (Goldring et al., 2011). Conse-
quently, scientists using hPSCs need to be vigilant to
monitor the cultures for the presence of genetic changes.
This necessitates a good understanding of the sensitivities
of different methods used for screening hPSC cultures,
as preparations of cells declared ‘‘normal’’ and ‘‘free of ge-
netic variants’’ according to a particular methodology
may nevertheless harbor variant cells below the level of
sensitivity.
Traditionally, testing of hPSC lines for gross chromo-
somal changes employed karyology by chromosome band-
ing of metaphase cells (Amps et al., 2011; Baker et al.,
2007). Although karyotyping allows examination of the
entire cell genome in a single assay, an often overlooked
issue in evaluating hPSC cultures is the sensitivity of karyo-
typing in the detection of a low-grade mosaicism. Clinical
cytogeneticists have an established set of criteria for the
number of metaphases that need to be screened to detect
the presence of variant cells in clinical samples with a
certain level of confidence. For example, analysis of 30Authors.
ns.org/licenses/by/4.0/).
metaphases excludes 10% mosaicism, whereas analysis of
50 metaphases excludes 6% mosaicism, both with 95%
confidence (Hook, 1977). However, such calculations are
based on a statistical random sampling of a homogeneous
population and there is a question of whether this is appli-
cable to hPSCs, given that they grow in adherent cultures as
colonies and may not behave as a homogeneous popula-
tion when dissociated.
Even with the appropriate numbers of metaphases
sampled, karyotyping has additional shortfalls. The anal-
ysis is limited by the fact that only mitotic cells can be as-
sessed, and it is also labor intense and relatively expensive.
Furthermore, karyotyping has a limited resolution of about
5–10 Mb (Shaffer et al., 2013). Although there are occa-
sions when abnormalities of less than 5 Mb could be de-
tected, this is limited to very specific karyotype changes
in which the chromosome band size, location (small, clear
separation from neighboring bands), and staining inten-
sity allows for such a small change to be visible. The
limited resolution may present a problem for assessing
the genetic status of hPSC cultures, as some of the most
common changes in hPSCs are present at a subkaryotype
level. Common structural variants are a gain of 20q11.21
copy-number variant (CNV) (Amps et al., 2011; Lefort
et al., 2008; Martins-Taylor et al., 2011) or loss of 10p13-
pter, 18q21-qter, and 22q13-qter (Amps et al., 2011). In
the International Stem Cell Initiative study, 20q CNV
was identified in more than 20% of the 120 lines analyzed,
and 22 of the lines harboring 20q CNV appeared normal
by karyology (Amps et al., 2011). Thus, detecting this
particularly frequent change usually requires the use of
alternative methods such as fluorescence in situ hybridiza-
tion (FISH) on interphase cells. The use of such a labor-
intensive and expensive method is limiting the frequency
of assessing genetic stability of hPSCs during routinemain-
tenance. Hence, there is a need for a rapid, cost-effective
assay that could be employed in common laboratory prac-
tice for regular screening of hPSCs for common genetic
changes.
qPCR offers a rapid alternative method to karyotyping or
FISH for detecting copy-number changes (Hoebeeck et al.,
2007). Unlike karyotyping, which provides a view of the
whole genome of a cell, qPCR and FISH-based methods
are target specific and hence typically serve as complemen-
tary analyses to genome-wide methods (Gekas et al., 2011;
Olde Nordkamp et al., 2009). D’Hulst et al. (2013) have em-
ployed qPCR as a way of rapid detection of common karyo-
typic changes in murine PSCs. Their assays for a gain of
chromosome 8 or a loss of chromosome Y were able to
detect abnormal cells when they were present in 10% or
more of cells in culture (D’Hulst et al., 2013). Similarly, Av-
ery et al. (2013) have used a qPCR assay for detecting a gain
of chromosome 20q11.21 in hPSCs. However, the limita-tions of this assay in respect of detecting low-level mosai-
cism in hPSCs remain unclear. More recently, digital PCR
has been developed to allow absolute quantification of
DNA and to afford higher sensitivity and precision in de-
tecting mutant alleles or copy-number variation (Vogel-
stein and Kinzler, 1999).
Here, we first tested the assumption that karyotyping
of hPSCs conforms to random sampling rules used in clin-
ical cytogenetics. We found that the numbers of meta-
phases required to be scored match well the numbers
anticipated from random sampling theory, and scoring
abnormal variants was not significantly distorted by
different growth characteristics of the variant cells. Further-
more, we report a qPCR assay as a rapid and accessible
method for assessing frequently occurring genetic aberra-
tions in hPSCs. Finally, our analyses show that although
karyotyping, FISH, qPCR, and digital PCR are effective
methods for monitoring the appearance of known com-
mon genetic variants, none of these methods reliably
detect variants if they are present at less than approxi-
mately 5%–10% of the cells in a culture.RESULTS
The Common Genetic Changes in hPSC Cultures
To analyze the spectrum of genetic changes in hPSCs, we
have assembled the published data reporting genetic ab-
normalities in human embryonic stem cells (Figure 1).
Although aberrations in all of the chromosomes were
observed, the distribution of cytogenetic abnormalities ap-
pears non-random, as was previously reported (Amps et al.,
2011). Themost common alterations are the gains of whole
chromosomes and duplications of chromosomal regions,
representing 42% and 31% of all karyotypic abnormalities
reported, respectively. The most common alteration de-
tected by chromosomal banding is a gain of chromosome
17 (17% of all karyotypic abnormalities reported). Addi-
tional chromosomes that are frequently gained (detected
by chromosomal banding) are chromosomes 12 (13.8%
of all karyotypic abnormalities reported), 1 (8%), 20
(7.4%), and X (5.5%). All of these chromosomes have
been reported at least twice as a sole abnormality in cells.
However, unlike chromosomes 12 and X, chromosome 1
is rarely gained as a whole chromosome and the gains of
chromosome 1 appear mostly as unbalanced structural
rearrangements. The overlapping structural variants have
been used to narrow down chromosomal regions on
frequently gained chromosomes to aid in identifying genes
that may be driving selective advantage of genetically
variant cells. The minimal amplicons for 1, 12, 17, and
20 have been identified at 1q25-q41, 12p11-pter, 17q25-
qter, and 20q11.21, respectively.Stem Cell Reports j Vol. 7 j 998–1012 j November 8, 2016 999
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Figure 1. Ideogram Summarizing the Reported Chromosome Changes in Human Embryonic Stem Cell Lines
Each colored bar represents one chromosome change occurrence in one cell line. Chromosome losses and gains are shown to the left and
right of the ideogram, respectively, except that in those instances where a single chromosome rearrangement results in a gain and a
loss, the colored bars are shown together for clarity. The cytogenetic changes are color coded: maroon, loss of a whole chromosome
(monosomy); red, loss via a structural chromosome rearrangement (unbalanced translocation or interstitial deletion); dark green, gain
of a whole chromosome (trisomy); light green, gain via a structural chromosome rearrangement (unbalanced translocation or inter-
stitial duplication); blue, occurrence of an apparently balanced rearrangement the nature of which is labeled. Instances in which a
change affected only a single chromosome are denoted by a filled circle, whereas changes associated with complex karyotypes (>5
unrelated chromosome aberrations) are denoted by a star. The list of references used for this summary can be found in the Supple-
mental References.Losses of chromosomes or chromosomal material occur
less frequently than the gains (22% of all karyotypic abnor-
malities reported are losses versus 73% reported gains) and
they occur predominantly as a loss of a chromosomal re-
gion (20% of reported changes) rather than monosomy
(2% of reported changes). A loss of an entire chromosome
was reported only for two of the somatic chromosomes
(chromosomes 9 and 13), although monosomy of these
chromosomes was not the only abnormality seen in the
cells. The loss of X chromosome was reported twice as a
sole abnormality. The minimal regions most commonly
subject to loss are 10p13-pter and 18q21-qter. Chromo-
somes that are rarely seen as gained or lost via unbalanced1000 Stem Cell Reports j Vol. 7 j 998–1012 j November 8, 2016rearrangements in hPSCs are chromosomes 4, 19, and 21
(Figure 1).
Sensitivity of Karyotyping in Detecting Mosaicism in
hPSC Cultures
To assess the sensitivity of chromosome banding in de-
tecting low levels of mosaicism in culture, we performed
mixing experiments of diploid (H7.s14, 46,XX) and
variant trisomic cells stably transfected with GFP (H7.s6-
GFP, 48,XX,+del(1)(p22p22),der(6)t(6;17)(q27;q1),+12[19]/
49,XX, idem,+20[1]). Samples with increasing ratios of
variant cells in diploid cultures (from 1% to 28%, as
assessed by high-content imaging of the numbers of
A B
C D
E F
Figure 2. Sensitivity of Karyotyping in De-
tecting Mosaicism in hPSC Cultures
Diploid (H7.s14) and aneuploid (H7.s6-GFP,
stably expressing GFP) cells were mixed at
different ratios. The percentage of aneuploid
cells was confirmed by imaging the cells on a
high-content microscopy platform and using
associated image analysis software to count
the number of aneuploid cells based on GFP
expression. Mosaic cultures containing (A)
1%, (B) 6%, (C) 9%, (D) 13%, (E) 18%, and
(F) 28% aneuploid cells within the diploid
cell population were subjected to karyotypic
analysis. Metaphase cells were scored for
the presence or absence of the abnormal
chromosome 6, der(6)t(6;17)(q27;q1) in
the mixed samples. Increasing numbers of
metaphases (from 5 to 100) were scored from
each sample. The numbers of abnormal cells
detected in triplicate analysis (red, green,
and blue circles) were plotted against sta-
tistically determined expected numbers of
abnormal cells (dashed lines) as detailed in
Table S1.GFP-expressing cells) were treated with colcemid and
processed for G-banding. Increasing numbers of unique
metaphases (from 5 to 100) were then sampled from the
slides containing the chromosomal spreads and chromo-
some numbers were counted in the cells (Figure 2). Overall,
the numbers of abnormal cells detected in the samples
fell within the expected confidence limits (Figure 2 and
Table S1). However, at higher ratios of mosaicism (>13%),
some of the numbers of abnormal cells detected were
higher than the statistically predicted ones (Figures 2D–
2F). To exclude a potential operator bias in detecting the
numbers of abnormal cells, a second independent analyst
scored the metaphases on the same cytogenetic slides
and a similar trend in the number of abnormal cells wasobserved (Figure S1). New cytogenetic slides were also
prepared from the existing samples and counted (Fig-
ure S2). A repeat of the experiment using tdTomato-labeled
diploid line (H7.s14-Tomato, 46,XX) and the GFP-labeled
variant line (H7.s6-GFP) also showed similar results, with
the numbers of abnormal cells matching well the statisti-
cally predicted numbers (Figure S3).
As an alternative way of constructing mosaic samples
and determining the ratios of abnormal cells present in
cultures, we dissociated diploid cells (H7.s14) and their
triploid counterparts (H7.s6-GFP) to single cells, counted
them, and seeded them into flasks. The mosaic cultures
were passaged once to further ensure inter-mixing of
normal and variant cells within the cultures. At the timeStem Cell Reports j Vol. 7 j 998–1012 j November 8, 2016 1001
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Figure 3. Sensitivity of Karyotyping in
Detecting Mosaicism in hPSC Cultures
Tested on a Different Pair of Normal and
Genetically Variant Cells
Diploid (H14.s9) and aneuploid (H14BJ1-
GFP) cells weremixed at different ratios. Flow
cytometry was used to determine the ratio of
abnormal cells in mixed cultures based on
their GFP expression. Mosaic cultures con-
taining (A) 2%, (B) 6%, (C) 10%, and (D)
19% aneuploid cells within the diploid
cell population were subjected to karyo-
typic analysis. Metaphase cells were scored
for the presence or absence of an addi-
tional abnormal chromosome 17, der(17)
del(17)(p13.3)hsr(17)(p11.2). Increasing
numbers of metaphases (from 5 to 100) were
scored from each sample. The numbers of
abnormal cells detected (red circles) were
plotted against statistically determined ex-
pected numbers of abnormal cells (dotted
lines) (Table S1).of passage each sample was split into duplicate flasks. Two
days after plating one of the flasks was used to determine
the ratios of normal and variant cells by flow cytometry,
whereas the duplicate flask was processed for G-banding.
The mosaic samples contained between 24% and 90%
abnormal cells (Figure S4A) which intermixed well with
the diploid cells, creating ‘‘salt and pepper’’ type colonies
(Figure S4B). Scoring of up to 50 metaphases from such
mosaic cultures also matched well the numbers of statisti-
cally predicted abnormal cells (Figure S4C and Table S1).
Finally, we repeated the latter mixing experiment using a
pair of normal and genetically variant sublines of the H14
hPSC line. The diploid (H14.s9 [46,XY]) and GFP-express-
ing variant cells (H14.BJ1-GFP [48,XY,+12,+17,der(17)
del(17)(p13)hsr(17)(p11.2)[10]]) were dissociated to single
cells, mixed at different ratios, and plated. Established cul-
tures were passaged once into duplicate flasks and pro-
cessed forG-banding or flow cytometry, as described above.
Similar to our observations on H7 line, scoring of up to 100
metaphases from mixed cultures with different ratios of
abnormal cells was in line with the statistically predicted
numbers (Figure 3 and Table S1).
Overall, in repeated experiments the numbers of meta-
phases scored as abnormal matched well the numbers1002 Stem Cell Reports j Vol. 7 j 998–1012 j November 8, 2016anticipated from random sampling theory, and scoring
genetically abnormal variants was not substantially dis-
torted by different growth characteristics of the variant
cells. However, the low level of mosaicism (1%) could not
be reliably detected even at 100 metaphases analyzed.
qPCR Assay for Detecting the Most Commonly
Identified Genetic Changes in hPSCs
We next sought to design a qPCR assay that could be used
as a fast and accessible method for detecting frequent
genetic changes in hPSCs. Given that whole or partial tri-
somies 1, 12, 17, and 20 account for the majority of aneu-
ploidies in hPSCs (Figure 1), we designed primers located
on these chromosomes. Chromosome 4 is rarely gained
or duplicated in hPSCs; therefore, we chose a gene on chro-
mosome 4 (RELL1) as a reference gene. All primer pairs were
designed to bind within the introns of selected genes. The
predicted PCR amplicons were checked for the absence of
EcoRI restriction site as the gDNA extracted from hPSCs
was digested with EcoRI to enable accessibility of primers
in PCR. Initially we designed multiple primer pairs for
each of the chromosomal loci and checked their specificity
using NCBI Primer-BLAST. To validate the primers empiri-
cally, we first used them in a qPCR reaction and compared
Table 1. Primers and Probes Used in qPCR
Gene Gene Location Primer Sequences (50-30) UPL Probe Amplicon Size (bp) Primer Efficiency (%)
NPHP4 1p36 F: ccggcctatcgtcactttt
R: gccggtgtgtgcagaact
8 60 94
CHD1L 1q12 F: aaaaacctaagtaacagagggacatt
R: tgtatctatgttgttgggattcatact
56 69 101
RELL1 4p14 F: tgcttgctcagaaggagctt
R: tgggttcaggaacagagaca
12 64 94
DPPA3 12p13.31 F: cgtagcgtcgttgcatca
R: tcctttttaccgttcctgaca
60 63 96
LGR5 12q21.1 F: gatatgttggggattgacacg
R: tgctcaaagaggacaaccttc
6 60 109
FLCN 17p11.2 F: tgcagtccacaatgacaagtg
R: ccatgagagccgaagactgt
68 74 101
TK1 17q23.2-q25.3 F: ggtgacagctgcttacagcttag
R: actggttgccaccttctcag
60 64 101
BCL2L1 20q11.21 F: tctgcagaaggctaccccta
R: tgctgtgtctaagacctctttcat
44 75 111
Gene name and location, primer sequences, and Universal Probe Library (UPL) probes used for amplification of target sequences. F, forward primer; R, reverse
primer.the average values of the cycle threshold (Cq) of technical
triplicates of the target gene to the reference gene on chro-
mosome 4 (RELL1). Primer pairs with a Cq value within
two units of the reference gene were tested for single prod-
uct amplification and primer efficiency. To ensure single
band amplification, we used primers in a qPCR reaction
with a melting curve analysis. Primer pairs that produced
a single amplicon were further tested for amplification
efficiency using a genomic DNA (gDNA) dilution series.
Primers with the efficiency in the range of 90%–115%
were selected as a final panel of primers (Table 1).
To obtain calibrator samples with which all other sam-
ples could be compared, we extracted gDNA from two cell
lines (H7.s14 and Shef6 8H12) with a known diploid num-
ber of chromosomes as assessed by G-banding (Table S2).
The calibrator lines were also diploid for 20q11.21 CNV
as assessed by FISH (Table S2). We first calculated the
copy numbers of loci for calibrator samples (relative to
each other) in a qPCR assay and then used three SDs of
the copy-number values of the calibrators as a cutoff point
for determining the gain or loss of chromosomal regions
(red lines on graphs in Figure 4). To validate our assay, we
obtained gDNA from a number of cell lines and their
subclones (Shef5, MasterShef 8, MasterShef 14, H14.s9,
H7.s14-Tomato, H14BJ1, Shef5-SF9, H7.s6, HES3-MIXL,
and Shef6 2A7), which were also independently assessed
by karyotyping. For each test line Cq values of target genes
were first normalized to the reference gene RELL1 on chro-
mosome 4 for that sample (dCq). The relative quantities oftarget genes were then calculated relative to the target
genes in each of the two calibrator samples (ddCq). The
relative amount of target in the sample was calculated as
2ddCq and the copy numbers were estimated as 2 * 2ddCq.
Using such relative quantification, our qPCR analysis de-
tected no abnormalities for tested loci in Shef5 (Figure 4A),
MasterShef 8 (Figure 4B),MasterShef 14 (Figure 4C), H14.s9
(Figure 4D), and H7.s14-Tomato (Figure 4E) hPSC lines, as
copy-number values for all of the tested target genes were
approximately 2. The normal karyotypes of these lines
were confirmed by an independent cytogenetic analysis
(Table S2). On the other hand, qPCR assay revealed copy-
number changes in the H14BJ1 line indicating gains of
chromosomes 12, 17, and 20q (Figure 4F). Chromosomes
12, 17q, and 20q were present at three copies, whereas
the quantification of copy numbers for chromosome
17p11.2 in the qPCR assay indicated a presence of 33
copies. The huge increase in copy numbers detected by
qPCR is consistent with a homogeneous staining region
indicating amplification of 17p11.2 seen by G-banding
(Figure 4F and Table S2).
Shef5-SF9 line showed gains of chromosome 17p and
20q (Figure 4G). These results were also independently
confirmed by karyotyping and FISH for chromosome
20q (Table S2). In the H7.s6 line, we detected a gain of
chromosome 1q, 17q, and 20q by qPCR (Figure 4H). The
gains of 1q and 17q were consistent with G-banding data
showing an abnormal karyotype with an additional
structurally abnormal chromosome 1 and an unbalancedStem Cell Reports j Vol. 7 j 998–1012 j November 8, 2016 1003
rearrangement between chromosomes 6 and 17, resulting
in 17q gain in all cells examined (Table S2). A gain of chro-
mosome 20q was not apparent by G-banding (Table S2).
The qPCR assay for HES3-MIXL line revealed a copy-
number change in chromosome 20q (Figure 4I). This result
was not apparent by karyotyping, but was confirmed by
FISH analysis (Table S2). However, G-banding highlighted
an abnormality of chromosome 10 in 2 out of 30 HES3-
MIXL cells analyzed, a difference not detected by qPCR as
chromosome 10 primers were not included in the panel.
Finally, Shef6 2A7 subline also showed a gain of chromo-
some 20q in the qPCR assay but appeared normal by karyo-
typing (Figure 4J and Table S2). The validity of the qPCR
result was subsequently confirmed by FISH analysis, which
revealed 41% of cells with a chromosome 20q gain (Table
S2). Thus, for the panel of cells tested qPCR analysis
matched the karyotyping and FISH data. A copy-number
change in chromosome 20q was detected in four
lines, which appeared normal for chromosome 20q by
G-banding.
Sensitivity of qPCR Assay versus Digital Droplet PCR
and FISH in Detecting Mosaicism in hPSC Cultures
The sensitivity of PCR-based methods is known to depend
on the magnitude of the copy-number change, with a dif-
ference between zero and one copy being easier to detect
than a difference between two and three copies (Whale
et al., 2012). We tested this by mixing gDNA of male and
female cell lines at different ratios and then performing a
qPCR for SRY gene on chromosome Y. We observed a sig-
nificant difference in the copy-number change when
male gDNA (with one copy of SRY) spiked into the gDNA
from female cells (with no copies of SRY) was present at
as low as 0.5% (p < 0.05, Student’s t test for sample with
0% male DNA versus the sample with 0.5% male DNA)
(Figure S5). However, the majority of aberrations observed
in hPSCs (as summarized in Figure 1) resulted in a change
in the copy number of chromosomal regions from two
copies in the normal diploid cell to three copies in the
aneuploid cell. Hence, to determine the sensitivity of the
qPCR assay in detecting mosaicism in hPSC cultures, we
constructed mosaic samples by mixing diploid cells with
increasing numbers of cells that had a complex abnormal
karyotype, including a gain of chromosome 17q. After
mixing the cells, each sample was split into two tubes,
one of which was processed for gDNA extraction and the
other for FISH analysis. Copy-number analysis for TK1
gene (located on chromosome 17q23.2-q25.3) showed an
increase in the copy-number values between two copies
in the sample with 0% abnormal cells and three copies
in 100% abnormal sample (Figure 5A). A significant
difference in the copy number compared with 0% control
was evident in the samples with 10% abnormal cells1004 Stem Cell Reports j Vol. 7 j 998–1012 j November 8, 2016(p < 0.001; Student’s t test for the biological triplicate
of copy-number values in 0% versus 10% samples). The
same gDNA samples were also tested in the digital droplet
PCR (ddPCR) assay on a Bio-Rad QX200 platform, which
separates the PCR mixture into 20,000 droplets. The
ddPCR was performed using a commercial TaqMan CNV
assay for TK1 and the TaqMan Copy Number Reference
Assay for TERT (chromosome 5p15.33). A significant dif-
ference in the copy-number values in the biological tripli-
cates was noted when abnormal cells were present at 10%
or more of the total cell numbers (p < 0.05, Student’s t test)
(Figure 5B). Testing of the same samples on the RainDrop
Digital PCR system (RainDance Technologies), which can
separate PCR reactions in up to 10 million droplets, al-
lowed detection of the variant cells when they were pre-
sent at 5% in the mixed samples (p < 0.01, Student’s
t test), but the very low levels of mosaicism were still not
detectable (Figure S5B). Finally, we also tested the same
set of samples by FISH using a probe at 17q22. The FISH
analysis of a 100 interphase cells detected the abnormal
cells when they were present at 5% or more (p < 0.001,
Student’s t test for the biological triplicate of 0% versus
5% samples) (Figure 5C). The analysis of 1,000 cells
improved the sensitivity of the FISH assay and allowed
the abnormal cells to be detected when they were present
at 1% (p < 0.05, Student’s t test for the biological triplicate
of 0% versus 1% samples) (Figure 5D).
To determine the sensitivity of the qPCR assay in detect-
ing a smaller structural genetic change, such as the gain of
CNV 20q11.21, we mixed clonal sublines with or without
the 20q11.21 gain as determined by FISH analysis on inter-
phase cells (data not shown). After mixing the cells each
sample was split into two tubes, one of which was pro-
cessed for gDNA extraction and the other for FISH analysis.
Control samples (0% and 100% variant cells) were also
tested at the same time. The qPCR assay was able to detect
abnormal cells in culture when theywere present at around
10%–20% of cells in the mosaic samples across biological
triplicates (Figure 6A). The ddPCR assay was performed
on the Bio-Rad QX200 platform using commercial TaqMan
CNV assay for BCL2L1 and the TERT TaqMan Copy Num-
ber Reference Assay. A significant difference in the copy-
number values in the biological triplicates was noted
when abnormal cells were present at 5% or more of the to-
tal cell numbers (p < 0.005, Student’s t test) (Figure 6B). We
also reliably detected abnormal cells by FISH only when
they were present at 10% or more in the mixed samples
(p < 0.005, Student’s t test) (Figure 6C). Increasing the num-
ber of interphase cells analyzed to 1,000 improved the
sensitivity but only down to 5% (p < 0.05, Student’s t test
for 0% versus 5% samples) (Figure 6D). Hence, FISH ap-
peared slightly less sensitive in detecting chromosome
20qCNV than the gain of 17q, possibly due to the difficulty
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in resolving the presence of an additional signal on a
tandemly duplicated region.DISCUSSION
A particular safety concern for the use of hPSCs in regener-
ativemedicine is the presence of genetic changes that occur
upon culture. Given the range of commonly occurring
changes in hPSCs, it is not possible to recommend a single
method that could detect all possible types of changes with
an equally high resolution and/or accuracy. Nonetheless,
having a good understanding of the caveats associated
with particular methods is important for any risk/benefit
analysis. Here we investigated the sensitivity of karyotyp-
ing, PCR-based methods, and FISH to gain a clear under-
standing of the advantages and, particularly, limitations
of different methods for detecting genetic mosaicism in
hPSC cultures.
For karyotyping, we questioned whether the statistical
assumptions currently used in clinical cytogenetic practice
also apply to hPSCs due to the possible distorting effects
of culturing and sampling conditions of hPSCs on the
outcome of these tests. Our results from the mixing exper-
iments confirmed that overall the observed numbers of
abnormal hPSCs fall within the expected statistical as-
sumptions, and scoring abnormal variants was not sub-
stantially distorted by different growth characteristics of
the variant cells. In some experiments at higher percent-
ages of abnormal cells in mosaic cultures (>13%), a few of
the observed numbers of abnormal cells were higher than
the statistically predicted ones. This overestimation of the
number of abnormal cells may be due to a difference in
cell-cycle time between normal and variant cells. Indeed,
we have previously reported a faster cycling time of
aneuploid cells compared with their diploid counterparts
(Barbaric et al., 2014). As karyotyping relies on cells ar-
rested in metaphase, a different proliferative activity of
cells within a mosaic population may bias the analysis to-
ward the more proliferative cells (Gohring et al., 2011).
This interpretation is supported by results from FISH on
interphase cells from the same samples, where detected
numbers of abnormal cells do not fall outside the upper
limit of statistically expected numbers (data not shown).
Thus, karyotyping ofmosaic cultures entailing variant cells
with a high proliferative activity would tend to overesti-Figure 4. qPCR Assay for Detecting Common Genetic Changes in h
Copy-number values for target genes on commonly amplified chromo
MasterShef 14, (D) H14.s9, (E) H7.s14-Tomato, (F) H14BJ1, (G) Shef5-
means of copy numbers calculated relative to each of the calibrator lin
copy-number values of calibrator samples.
1006 Stem Cell Reports j Vol. 7 j 998–1012 j November 8, 2016mate, rather than underestimate, the presence of variant
cells.
Like any other method, karyotyping cannot prove the
absence of variant cells. Nonetheless, mosaicism can be
excluded to a certain degree by analyzing an appropriate
number of metaphases (Hook, 1977). The exact number
of metaphases scored may depend on the ultimate applica-
tion of cells. For example, for routine culturing of hPSCs
scoring of 20 or 30metaphases may be sufficient, as this al-
lows exclusion of 14% or 10% of mosaicism at 95% confi-
dence, respectively. However, detection of very low levels
of mosaicism (<1%) would require testing of more than
500 metaphases, which is impractical for routine testing
of cultures but may be warranted if the cells are being
used in clinical applications. Given this dependence of
the sensitivity of karyotyping on the numbers of meta-
phases analyzed, any karyotyping report and/or published
data should clearly indicate the numbers of metaphases
scored.
One drawback to karyotyping in the context of routine
laboratory practice is the need for expert cytogenetics ana-
lyses, which can hamper the frequency of the testing. Yet
variant hPSCs with common genetic changes rapidly
outcompete normal cells in culture, making early detection
and frequent testing for abnormalities essential (Olariu
et al., 2010). With this in mind, we designed a qPCR assay
for detecting common genetic changes in hPSCs. When
tested on a panel of cell lines, our assay accurately re-
flected the data obtained by karyotyping and/or FISH.
The simplicity of the method allows for the data to be ob-
tained within the same day, making it an ideal approach
for routine screening of the common changes that occur
in hPSC lines. A disadvantage of the qPCR-based assess-
ment (which is also true for FISH) is that the assays can
only detect changes at predetermined loci rather than
assess the whole genome, and so they do not negate the
need for detailed genetic analysis to detect other changes.
Nonetheless, due to the non-random changes observed in
hPSCs it should be possible to create a panel of primers
that would detect the majority of the changes. We esti-
mated that the panel of primers used in this study would
detect about 45% of the reported genetic changes summa-
rized in Figure 1. The flexibility of the method allows for
further primer pairs to be designed to cover additional re-
gions in the genome, although this would increase the
overall cost of screening.PSCs
somal regions for the hPSC lines (A) Shef5, (B) MasterShef 8, (C)
SF9, (H) H7.s6, (I) HES3-MIXL, and (J) Shef6 2A7. Plotted values are
es ± SEM. Red lines represent cutoff levels calculated as 3 SDs of the
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Figure 5. Sensitivity of Different Methods for Detecting Mosaicism of Chromosome 17q Trisomy in hPSC Cultures
(A) qPCR analysis of samples with ratios of abnormal cells ranging from 0% to 100%. The panels from left to right represent three biological
replicates. Plotted values on each graph are copy-number means of technical triplicates ± SEM.
(legend continued on next page)
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Unlike G-banding, which generally may not be able to
detect changes smaller than 5 Mb, qPCR and FISH are use-
ful for detecting small amplifications and deletions. A case
in point is the gain of chromosome 20q11.21. The gain of
20q11.21 is a particularly insidious genetic aberration as it
occurs in many cell lines with no overt karyotypic changes
(Amps et al., 2011). The 20q11.21 gain appears relatively
frequently and, once acquired, confers selective advantage
to variant cells, which rapidly overtake the culture (Amps
et al., 2011; Avery et al., 2013). Thus, hPSC cultures should
be regularly tested for the chromosome 20q CNV. Whereas
FISH and karyotyping typically require specialist staff and
often must be outsourced at costs of up to US$850, the
qPCR can usually be performed in-house for the cost of
reagents.
The sensitivity of the qPCR assay of around 10% for copy-
number changes allows genetic variants to be detected
before they overtake the cultures and mosaic cultures can
be either discarded or recloned. We did not achieve an
improvement in the sensitivity below 5% when using
ddPCR. The sensitivity of the PCR-basedmethods in detect-
ing copy-number changes depends on both the magnitude
of the copy-number change and the frequency of the
abnormal cells in mosaic samples. Indeed, the detection of
a new haplotype in the mosaic sample allows detection of
a copy-number change by qPCR even when variant cells
are present in as low as 0.5% of the sample, as we demon-
strated using a dilution series of a sample with one copy of
chromosome Y. However, majority of genetic changes in
hPSCs entail a change in the copy numbers from two to
three copies, which would equate to a 50% discrimination
between pure populations of triploid cells compared with
the diploid counterparts (1.5:1). However, when the ratio
of variant cells decreases to 10% of the total cells in mosaic
cultures, the assay would require discrimination of only
5% (1.05:1), and at 1% mosaicism of only 0.5% (1.005:1).
Although we were unable to achieve the sensitivity of less
than 5% with standard protocols used in ddPCR, further
optimization (e.g., using increasing amounts of DNA or
increased number of assays in commonly gained regions)
may allow for improved sensitivity.
The sensitivity of 5%–10% obtained by PCR-based
methods and FISH may be suitable for routine culturing
of cells, but the applications of hPSCs in the clinic
will likely require a more rigorous sensitivity. Some of(B) ddPCR analysis of samples with ratios of abnormal cells ranging f
Plotted on each graph are copy-number values and the Poisson distri
(C) FISH analysis of samples containing 0%–100% cells with a gain of
Plotted values on each graph are percentage of cells with amplification
expected values for each mixed sample.
(D) FISH analysis of samples containing 0% and 1% cells with a g
amplification among 1,000 cells analyzed. Plotted values are average
1008 Stem Cell Reports j Vol. 7 j 998–1012 j November 8, 2016the alternative methods for detection of genetic aberra-
tions in hPSCs that were not included in our study
include comparative genomic hybridization (CGH) or
SNP array platforms, e-karyotyping, and next-generation
sequencing. Previous studies on the sensitivity of CGH
and SNP arrays in detecting mosaicism in various clinical
samples estimated the sensitivity of 8%–20% (Ballif et al.,
2006; Cross et al., 2007; Valli et al., 2011), whereas an
estimated sensitivity of e-karyotyping is around 30%
(Ben-David et al., 2013).
Comprehensive genomic profiling is likely to uncover a
range of genetic aberrations in a preparation of cells. How-
ever, of those changes that are acquired during culture of
hPSCs many appear to confer selective growth advantage
to the undifferentiated cells, but their consequences
for behavior of particular differentiated cells remain un-
known. Overall, our evaluation of the commonly em-
ployed methods for genetic testing of hPSCs revealed their
limit ofmosaicismdetection to be around 5%–10%. Thus, a
preparation of cells could be declared ‘‘genetically normal’’
but nevertheless harbor small populations of variant cells,
the consequences of which for an experimental outcome
or transplantation to a patient remain unknown. Recogni-
tion of this point is crucial for developing strategies for
routine laboratory practice as well as the regulation for
the use of hPSCs in regenerative medicine. New strategies
for detecting mosaicism may help, although it is unlikely
that even whole-genome systems can be made sufficiently
sensitive to eliminate the possibility of mosaicism. Thus, it
becomes essential to assess the consequences of specific
changes, particularly those that occur commonly, for
the functional behavior of particular differentiated cells.
Assessment of potential risks will then depend on cell types
in question and the types of application.EXPERIMENTAL PROCEDURES
Human Pluripotent Stem Cell Culture
Stock cultures of hPSC lines (see Supplemental Experimental Pro-
cedures) were maintained at 37C under a humidified atmosphere
of 5% CO2 in air. For routine maintenance, cells were grown either
on Matrigel (BD Biosciences) in mTESR medium (StemCell
Technologies), or on vitronectin (Life Technologies) in Essential
8 (Life Technologies), or on CELLStart (Life Technologies) in
NutriStem medium (Stemgent).rom 0% to 100%. The panels represent three biological replicates.
bution at 95% confidence interval.
chromosome 17q. The panels represent three biological replicates.
among 100 cells analyzed. Dotted lines on each graph represent the
ain of chromosome 17q, shown as the percentage of cells with
s of biological triplicates ± SD.
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Figure 6. Sensitivity of Different Methods for Detecting Mosaicism of Chromosome 20q11.21 CNV in hPSC Cultures
(A) qPCR analysis of samples with ratios of abnormal cells ranging from 0% to 100%. The panels represent three biological replicates.
Plotted values on each graph are copy-number means of technical triplicates ± SEM.
(legend continued on next page)
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Fluorescence In Situ Hybridization
The cells were pelleted via centrifugation and resuspended in
prewarmed 0.0375 M KCl solution and incubated for 10 min.
Following centrifugation the cells were resuspended in fixative
(3:1 methanol/acetic acid). One drop of suspension was dropped
onto a glass microscope slide (Sigma). The BCL2L1 FISH probe
was a spectrum green fluorescently labeled BAC (RP5-857M17,
almost 100 kb) provided by BlueGnome (Illumina), and covers
the genes BCL2L1, COX4I2, and the 30 end of ID1. For 20q-telo-
mere detection, the Vysis (Abbott Molecular) probes TelVysion
20q-telomere (spectrum orange) were used. For detection of chro-
mosome17p/q copynumber, the Kreatech ISO17q (specific for the
TP53 gene at 17p13 labeled red and theMPO gene at 17q22 labeled
green) probes were used. Probe and slides were denatured together
at 72C for 2 min in a PTC-200 DNA Engine (Peltier Thermal
Cycler, MJ Research) and incubated at 37C for 16 hr for hybridiza-
tion. Slides werewashed in 0.43 sodium citrate (AbbottMolecular)
with 0.3% Tween 20 (Sigma) and 23 sodium citrate with 0.1%
Tween 20. Coverslips were mounted on the slides in Vectashield
Mounting Medium with DAPI (Vector Laboratories). Either 100
or 1,000 interphase cells were analyzed on an Olympus BX51 fluo-
rescent microscope, as indicated.
Mixing Experiments for Detecting the Sensitivity of
Karyotyping
Diploid hPSC sublines (H7.s14, H7.s14-Tomato, or H14.s9) were
mixed at different ratios with their aneuploid counterparts
(H7.s6-GFP or H14BJ1-GFP) as detailed in Supplemental Experi-
mental Procedures. Ratios of abnormal cells in culture were as-
sessed either by high-content imaging using the InCell Analyzer
1000 (GE Healthcare) and associated image analysis software
(Developer Toolbox 1.7, GE Healthcare) or by flow cytometry of
a duplicate flask using BD FACSJazz (BD Biosciences). Mosaic cul-
tures were treated with colcemid and processed for G-banding
(Supplemental Experimental Procedures).
Mixing Experiments for Detecting Sensitivity of PCR-
Based Methods and FISH
For testing the sensitivity of methods in detecting a gain of chro-
mosome 17q, we usedH7.s14 diploid subline andH7.s6-GFP aneu-
ploid subline trisomic for chromosome 17q. For chromosome 20q
sensitivity, we used clonal Shef6 8H12 and Shef6 2A subline,
diploid and trisomic for 20q, respectively. All sublines were grown
onMatrigel inmTESR prior to the experiment and then dissociated
using trypsin and counted. After mixing the cells to achieve
0.01%–100% of abnormal cells within the diploid population,
eachmosaic samplewas split into two tubes, one of whichwas pro-
cessed for FISH analysis and the other one for gDNA extraction.(B) ddPCR analysis of samples with ratios of abnormal cells ranging f
Plotted on each graph are copy-number values and the Poisson distri
(C) FISH analysis of samples containing 0%–100% cells with a gain of
Plotted values on each graph are percentage of cells with amplification
expected values for each mixed sample.
(D) FISH analysis of samples containing 0%, 0.01%, 1%, and 5% of ce
with amplification among 1,000 cells analyzed. Plotted values are av
1010 Stem Cell Reports j Vol. 7 j 998–1012 j November 8, 2016The control samples (0% variant cells) were also tested at the
same time. For testing the sensitivity of qPCR assay in detecting
a change of copy numbers from 0 to 1, we spiked gDNA from a
male hPSC line (MasterShef 8, 46,XY) into gDNA from a female
line (MasterShef 14, 46,XX) in a range of ratios from 0.01%
to 100%. qPCR was used to detect a copy number of SRY (chromo-
some Yp11.32). The sequences of the forward and reverse
primers used in the qPCR reaction were aaaattggcgattaagtcaaattc
and ctgcctccctgactgctct, respectively. The qPCR was performed in
10-mL reactions as detailed below.
qPCR for Determining Copy-Number Changes of
Target Genes
Primers for qPCR were designed and validated as detailed in
Supplemental Experimental Procedures. qPCR was performed
in 10-mL reactions in triplicates or quadruplicates, using gene-
specific primers (Table 1), probes from the Universal Probe Library
(Table 1), and TaqMan Fast Universal PCR Master Mix (Life Tech-
nologies). Each PCR reaction contained 13manufacturer’s buffer,
100 nMof each of the forward and reverse primers, and 10 or 20 ng
of DNA template. No template controls were also included on each
plate. Samples were heated to 50C for 2 min and denatured at
95C for 10 min. This was followed by 40 cycles of 95C for 15 s
and 60C for 1 min. Reactions were run on 384-well plates on
the QuantStudio 12K Flex Real-Time PCR System (Applied Bio-
systems, Life Technologies). The Cq values were obtained from
the QuantStudio 12K Flex Software with auto baseline settings
and were then exported to Excel for copy-number analysis using
the relative quantification method (2ddCq) (as detailed in Sup-
plemental Experimental Procedures).
Digital Droplet PCR on the Bio-Rad QX200 Platform
A copy-number variation experiment was performed using a
TaqMan assay specific to BCL2L1 (Life Technologies) or TK1 (Life
Technologies) against the VIC-labeled reference assay (TERT)
(Life Technologies) set at two copies (CNV2) on the Bio-Rad
QX200 ddPCR system (Bio-Rad). Reaction mixtures (20 mL) con-
tained 1 mL of DNA extract, 13 ddPCR Supermix for probes (Bio-
Rad), 225 nM of each primer, and 50 nM of each probe. Reaction
mixes were loaded either into DG8 cartridges together with
70 mL of droplet oil per sample; droplets were generated using
the QX100 Droplet Generator or loaded in plate format into the
Bio-Rad QX200 AutoDG and generated as per the manufacturer’s
instructions. The oil/reagent emulsion was transferred to a 96-
well semi-skirted plate (Eppendorf) and the sampleswere amplified
on the Bio-Rad C1000 Touch thermocycler (95C for 10 min, fol-
lowed by 40 cycles of 94C for 30 s and 60C for 60 s, with a final
elongation step of 98C for 10 min). The plate containing therom 0% to 100%. The panels represent three biological replicates.
bution at 95% confidence interval.
chromosome 20q. The panels represent three biological replicates.
among 100 cells analyzed. Dotted lines on each graph represent the
lls with a gain of chromosome 20q, shown as the percentage of cells
erages of biological triplicates ± SD.
droplet amplicons was subsequently loaded into the QX200
Droplet Reader (Bio-Rad). Analysis was performed using Quanta-
soft software (Bio-Rad).
Statistical Analysis
Data were statistically analyzed using Excel. p < 0.05 defined statis-
tical significance. To test the statistical difference between different
levels of mosaicism across biological replicates in the ddPCR,
we first normalized 0% samples within each biological replicate
to 2 and normalized the mosaic samples to the 0% sample.
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